US Stem Cell Clinics, Patient Safety, and the FDA
By Leigh Turner,
Trends in Molecular Medicine
| 05. 01. 2015
Untitled Document
Clinics advertising adipose-derived autologous ‘stem cell treatments’ are proliferating across the USA. The rapid spread of businesses promoting unapproved stem cell interventions reveals a widening gulf between federal regulations governing stem cell based therapies and a marketplace where few companies selling such interventions are subjected to regulatory action. Fatal outcomes, complications, and lawsuits have not slowed this rush to the marketplace [1, 2, 3, 4].
Cell Surgical Network (CSN) is the most visible example of the emergence of US businesses selling unlicensed stem cell interventions. CSN is an association of over 50 clinics promoting adipose-derived ‘stem cell treatments’ for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis, muscular dystrophy, stroke, cardiomyopathy, and many other diseases and injuries. Another company, StemGenex, promotes access to commercial ‘stem cell therapy studies’ for Alzheimer's disease, multiple sclerosis, type I and type II diabetes, Crohn's disease, and other illnesses. Between 100 and 200 such businesses are estimated to be operating in the USA [5]. The multiplication of such clinics represents a dramatic shift in which individuals can...
Related Articles
A Review of Exposed by Becky McClain
“Do not get lost in a sea of despair. Be hopeful, be optimistic. Our struggle is not the struggle of a day, a week, a month, or a year, it is the struggle of a lifetime. Never, ever be afraid to make some noise and get in good trouble, necessary trouble.”
— John Lewis
Becky McClain became famous when she successfully sued Pfizer, one of the very largest pharmaceutical and biotech companies. She...
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
By Carter Sherman, The Guardian | 12.08.2025
A huge defense policy bill, revealed by US lawmakers on Sunday, does not include a provision that would have provided broad healthcare coverage for in vitro fertilization (IVF) for active-duty members of the military, despite Donald Trump’s pledge...
